• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Bayesian sample size determination using commensurate priors to leverage pre-experimental data.使用相称先验来利用实验前数据的贝叶斯样本量确定。
Biometrics. 2022 Mar 6;79(2):669-683. doi: 10.1111/j.1541-0420.2005.00454.x.
2
Bayesian sample size determination using commensurate priors to leverage preexperimental data.使用相称先验来利用预实验数据的贝叶斯样本量确定。
Biometrics. 2023 Jun;79(2):669-683. doi: 10.1111/biom.13649. Epub 2022 Mar 28.
3
Bayesian sample size determination in basket trials borrowing information between subsets.篮子试验中基于贝叶斯方法的样本量确定:子集间信息借用
Biostatistics. 2023 Oct 18;24(4):1000-1016. doi: 10.1093/biostatistics/kxac033.
4
Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.贝叶斯动态借用不完美匹配历史对照的批判性评价。
Pharm Stat. 2020 Sep;19(5):613-625. doi: 10.1002/pst.2018. Epub 2020 Mar 17.
5
Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study.将个体历史对照和综合治疗效果估计纳入贝叶斯生存试验:一项模拟研究。
BMC Med Res Methodol. 2019 Apr 24;19(1):85. doi: 10.1186/s12874-019-0714-z.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Robust meta-analytic-predictive priors in clinical trials with historical control information.具有历史对照信息的临床试验中的稳健元分析预测先验。
Biometrics. 2014 Dec;70(4):1023-32. doi: 10.1111/biom.12242. Epub 2014 Oct 29.
8
Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study.用于增强对照设计的倾向得分整合贝叶斯先验方法:一项模拟研究
J Biopharm Stat. 2022 Jan 2;32(1):170-190. doi: 10.1080/10543406.2021.2011743. Epub 2021 Dec 23.
9
Borrowing of information across patient subgroups in a basket trial based on distributional discrepancy.基于分布差异的篮子试验中患者亚组间信息的借用。
Biostatistics. 2022 Jan 13;23(1):120-135. doi: 10.1093/biostatistics/kxaa019.
10

引用本文的文献

1
Bayesian modelling strategies for borrowing of information in randomised basket trials.随机分组篮子试验中信息借用的贝叶斯建模策略。
J R Stat Soc Ser C Appl Stat. 2022 Nov;71(5):2014-2037. doi: 10.1111/rssc.12602. Epub 2022 Oct 28.
2
Design and analysis of umbrella trials: Where do we stand?伞形试验的设计与分析:我们目前的进展如何?
Front Med (Lausanne). 2022 Oct 12;9:1037439. doi: 10.3389/fmed.2022.1037439. eCollection 2022.

本文引用的文献

1
Borrowing of information across patient subgroups in a basket trial based on distributional discrepancy.基于分布差异的篮子试验中患者亚组间信息的借用。
Biostatistics. 2022 Jan 13;23(1):120-135. doi: 10.1093/biostatistics/kxaa019.
2
A Bayesian decision-theoretic approach to incorporate preclinical information into phase I oncology trials.贝叶斯决策理论在肿瘤 I 期临床试验中纳入临床前信息的应用。
Biom J. 2020 Oct;62(6):1408-1427. doi: 10.1002/bimj.201900161. Epub 2020 Apr 13.
3
Predictively consistent prior effective sample sizes.可预测一致性先验有效样本量。
Biometrics. 2020 Jun;76(2):578-587. doi: 10.1111/biom.13252. Epub 2020 Apr 6.
4
A robust Bayesian meta-analytic approach to incorporate animal data into phase I oncology trials.一种稳健的贝叶斯荟萃分析方法,用于将动物数据纳入肿瘤 I 期临床试验。
Stat Methods Med Res. 2020 Jan;29(1):94-110. doi: 10.1177/0962280218820040. Epub 2019 Jan 16.
5
Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosa.专家先验意见的引出:在儿童结节性多动脉炎MYPAN试验中的应用
PLoS One. 2015 Mar 30;10(3):e0120981. doi: 10.1371/journal.pone.0120981. eCollection 2015.
6
Bayesian methods for the design and interpretation of clinical trials in very rare diseases.用于极罕见疾病临床试验设计与解读的贝叶斯方法。
Stat Med. 2014 Oct 30;33(24):4186-201. doi: 10.1002/sim.6225. Epub 2014 Jun 23.
7
Mixtures of prior distributions for predictive Bayesian sample size calculations in clinical trials.临床试验中用于预测性贝叶斯样本量计算的先验分布混合。
Stat Med. 2009 Jul 30;28(17):2185-201. doi: 10.1002/sim.3609.
8
Bayesian sample size for exploratory clinical trials incorporating historical data.纳入历史数据的探索性临床试验的贝叶斯样本量
Stat Med. 2008 Jun 15;27(13):2307-27. doi: 10.1002/sim.3140.

使用相称先验来利用实验前数据的贝叶斯样本量确定。

Bayesian sample size determination using commensurate priors to leverage pre-experimental data.

作者信息

Zheng Haiyan, Jaki Thomas, Wason James M S

机构信息

MRC Biostatistics Unit, University of Cambridge, U.K.

Population Health Sciences Institute, Newcastle University, U.K.

出版信息

Biometrics. 2022 Mar 6;79(2):669-683. doi: 10.1111/j.1541-0420.2005.00454.x.

DOI:10.1111/j.1541-0420.2005.00454.x
PMID:38523700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7614678/
Abstract

This paper develops Bayesian sample size formulae for experiments comparing two groups, where relevant pre-experimental information from multiple sources can be incorporated in a robust prior to support both the design and analysis. We use commensurate predictive priors for borrowing of information, and further place Gamma mixture priors on the precisions to account for preliminary belief about the pairwise (in)commensurability between parameters that underpin the historical and new experiments. Averaged over the probability space of the new experimental data, appropriate sample sizes are found according to criteria that control certain aspects of the posterior distribution, such as the coverage probability or length of a defined density region. Our Bayesian methodology can be applied to circumstances that compare two normal means, proportions or event times. When nuisance parameters (such as variance) in the new experiment are unknown, a prior distribution can further be specified based on pre-experimental data. Exact solutions are available based on most of the criteria considered for Bayesian sample size determination, while a search procedure is described in cases for which there are no closed-form expressions. We illustrate the application of our sample size formulae in the design of clinical trials, where pre-trial information is available to be leveraged. Hypothetical data examples, motivated by a rare-disease trial with elicited expert prior opinion, and a comprehensive performance evaluation of the proposed methodology are presented.

摘要

本文针对比较两组的实验,推导了贝叶斯样本量公式,其中可以将来自多个来源的相关实验前信息纳入一个稳健先验中,以支持设计和分析。我们使用相称预测先验来借用信息,并进一步对精度设置伽马混合先验,以考虑对支撑历史实验和新实验的参数之间成对(不)相称性的初步信念。在新实验数据的概率空间上进行平均,根据控制后验分布某些方面的标准(如覆盖概率或定义密度区域的长度)找到合适的样本量。我们的贝叶斯方法可应用于比较两个正态均值、比例或事件时间的情况。当新实验中的干扰参数(如方差)未知时,可以根据实验前数据进一步指定先验分布。基于用于贝叶斯样本量确定的大多数标准,可得到精确解,而对于没有闭式表达式的情况,描述了一种搜索程序。我们说明了样本量公式在临床试验设计中的应用,其中可利用试验前信息。给出了由一个引出专家先验意见的罕见病试验激发的假设数据示例,以及对所提出方法的全面性能评估。